nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0343	0.749	CbGeAlD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.00704	0.139	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00353	0.0695	CbGpPWpGaD
Prilocaine—SCN1A—brainstem—peripheral nervous system neoplasm	0.00352	0.0768	CbGeAlD
Prilocaine—SCN2A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00339	0.0668	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00327	0.0644	CbGpPWpGaD
Prilocaine—SCN2A—brainstem—peripheral nervous system neoplasm	0.00323	0.0705	CbGeAlD
Prilocaine—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0023	0.0453	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00225	0.0443	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.00181	0.0356	CbGpPWpGaD
Prilocaine—Dermatitis atopic—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00193	CcSEcCtD
Prilocaine—SCN1A—cerebellum—peripheral nervous system neoplasm	0.00174	0.0379	CbGeAlD
Prilocaine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00192	CcSEcCtD
Prilocaine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00192	CcSEcCtD
Prilocaine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00172	0.00191	CcSEcCtD
Prilocaine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00172	0.00191	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00172	0.0339	CbGpPWpGaD
Prilocaine—Cardiac arrest—Etoposide—peripheral nervous system neoplasm	0.00172	0.0019	CcSEcCtD
Prilocaine—Anaemia—Topotecan—peripheral nervous system neoplasm	0.00171	0.0019	CcSEcCtD
Prilocaine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.00189	CcSEcCtD
Prilocaine—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.0017	0.00188	CcSEcCtD
Prilocaine—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.0017	0.00188	CcSEcCtD
Prilocaine—Neuropathy peripheral—Vincristine—peripheral nervous system neoplasm	0.00169	0.00187	CcSEcCtD
Prilocaine—Anaemia—Melphalan—peripheral nervous system neoplasm	0.00168	0.00186	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00166	0.0326	CbGpPWpGaD
Prilocaine—Syncope—Tretinoin—peripheral nervous system neoplasm	0.00165	0.00183	CcSEcCtD
Prilocaine—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.00165	0.00183	CcSEcCtD
Prilocaine—Sweating—Vincristine—peripheral nervous system neoplasm	0.00165	0.00182	CcSEcCtD
Prilocaine—Feeling hot—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00182	CcSEcCtD
Prilocaine—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00179	CcSEcCtD
Prilocaine—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00179	CcSEcCtD
Prilocaine—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00177	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.0016	0.0314	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00176	CcSEcCtD
Prilocaine—SCN2A—cerebellum—peripheral nervous system neoplasm	0.00159	0.0348	CbGeAlD
Prilocaine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00159	0.00176	CcSEcCtD
Prilocaine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00159	0.00176	CcSEcCtD
Prilocaine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00173	CcSEcCtD
Prilocaine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00173	CcSEcCtD
Prilocaine—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00154	0.0017	CcSEcCtD
Prilocaine—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.00154	0.0017	CcSEcCtD
Prilocaine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00151	0.00168	CcSEcCtD
Prilocaine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00151	0.00168	CcSEcCtD
Prilocaine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00151	0.00168	CcSEcCtD
Prilocaine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00166	CcSEcCtD
Prilocaine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00166	CcSEcCtD
Prilocaine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00166	CcSEcCtD
Prilocaine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00166	CcSEcCtD
Prilocaine—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00149	0.00165	CcSEcCtD
Prilocaine—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.00149	0.00165	CcSEcCtD
Prilocaine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00148	0.00164	CcSEcCtD
Prilocaine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00148	0.00164	CcSEcCtD
Prilocaine—Oedema—Melphalan—peripheral nervous system neoplasm	0.00148	0.00164	CcSEcCtD
Prilocaine—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00164	CcSEcCtD
Prilocaine—Shock—Tretinoin—peripheral nervous system neoplasm	0.00148	0.00164	CcSEcCtD
Prilocaine—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00148	0.00164	CcSEcCtD
Prilocaine—Dysarthria—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00163	CcSEcCtD
Prilocaine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00147	0.00163	CcSEcCtD
Prilocaine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00147	0.00163	CcSEcCtD
Prilocaine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00146	0.00162	CcSEcCtD
Prilocaine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00161	CcSEcCtD
Prilocaine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00161	CcSEcCtD
Prilocaine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00158	CcSEcCtD
Prilocaine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.0014	0.00155	CcSEcCtD
Prilocaine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.0014	0.00155	CcSEcCtD
Prilocaine—SCN3A—cerebellum—peripheral nervous system neoplasm	0.0014	0.0306	CbGeAlD
Prilocaine—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00139	0.00154	CcSEcCtD
Prilocaine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00154	CcSEcCtD
Prilocaine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00139	0.00153	CcSEcCtD
Prilocaine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00151	CcSEcCtD
Prilocaine—Dysarthria—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00151	CcSEcCtD
Prilocaine—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.00137	0.00151	CcSEcCtD
Prilocaine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00136	0.0015	CcSEcCtD
Prilocaine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.0015	CcSEcCtD
Prilocaine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00135	0.00149	CcSEcCtD
Prilocaine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.00149	CcSEcCtD
Prilocaine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00148	CcSEcCtD
Prilocaine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00148	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00133	0.0263	CbGpPWpGaD
Prilocaine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00133	0.00147	CcSEcCtD
Prilocaine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00145	CcSEcCtD
Prilocaine—Neuropathy—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00145	CcSEcCtD
Prilocaine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00145	CcSEcCtD
Prilocaine—Pain—Topotecan—peripheral nervous system neoplasm	0.00129	0.00143	CcSEcCtD
Prilocaine—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00143	CcSEcCtD
Prilocaine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00128	0.00142	CcSEcCtD
Prilocaine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.00142	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00128	0.0252	CbGpPWpGaD
Prilocaine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00127	0.00141	CcSEcCtD
Prilocaine—Pain—Melphalan—peripheral nervous system neoplasm	0.00127	0.0014	CcSEcCtD
Prilocaine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00138	CcSEcCtD
Prilocaine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00125	0.00138	CcSEcCtD
Prilocaine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00124	0.00138	CcSEcCtD
Prilocaine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00124	0.00137	CcSEcCtD
Prilocaine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00124	0.00137	CcSEcCtD
Prilocaine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.00137	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00124	0.0243	CbGpPWpGaD
Prilocaine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.00136	CcSEcCtD
Prilocaine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00136	CcSEcCtD
Prilocaine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00135	CcSEcCtD
Prilocaine—Neuropathy—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00134	CcSEcCtD
Prilocaine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00133	CcSEcCtD
Prilocaine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.0012	0.00133	CcSEcCtD
Prilocaine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00132	CcSEcCtD
Prilocaine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00132	CcSEcCtD
Prilocaine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00131	CcSEcCtD
Prilocaine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00118	0.0013	CcSEcCtD
Prilocaine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00116	0.00128	CcSEcCtD
Prilocaine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00127	CcSEcCtD
Prilocaine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00126	CcSEcCtD
Prilocaine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00126	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00112	0.0221	CbGpPWpGaD
Prilocaine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00124	CcSEcCtD
Prilocaine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00124	CcSEcCtD
Prilocaine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00124	CcSEcCtD
Prilocaine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00112	0.00123	CcSEcCtD
Prilocaine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00123	CcSEcCtD
Prilocaine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00122	CcSEcCtD
Prilocaine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00122	CcSEcCtD
Prilocaine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00122	CcSEcCtD
Prilocaine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.0011	0.00122	CcSEcCtD
Prilocaine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.0011	0.00121	CcSEcCtD
Prilocaine—Oedema—Vincristine—peripheral nervous system neoplasm	0.0011	0.00121	CcSEcCtD
Prilocaine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00109	0.00121	CcSEcCtD
Prilocaine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00109	0.0012	CcSEcCtD
Prilocaine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00119	CcSEcCtD
Prilocaine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00119	CcSEcCtD
Prilocaine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00108	0.00119	CcSEcCtD
Prilocaine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00106	0.00118	CcSEcCtD
Prilocaine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00118	CcSEcCtD
Prilocaine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00106	0.00117	CcSEcCtD
Prilocaine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00105	0.00116	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00116	CcSEcCtD
Prilocaine—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00115	CcSEcCtD
Prilocaine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00102	0.00113	CcSEcCtD
Prilocaine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00113	CcSEcCtD
Prilocaine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00112	CcSEcCtD
Prilocaine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00112	CcSEcCtD
Prilocaine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00112	CcSEcCtD
Prilocaine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00112	CcSEcCtD
Prilocaine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00112	CcSEcCtD
Prilocaine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00101	0.00111	CcSEcCtD
Prilocaine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.001	0.00111	CcSEcCtD
Prilocaine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000993	0.0011	CcSEcCtD
Prilocaine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000993	0.0011	CcSEcCtD
Prilocaine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000985	0.00109	CcSEcCtD
Prilocaine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000973	0.00108	CcSEcCtD
Prilocaine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00097	0.00107	CcSEcCtD
Prilocaine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00097	0.00107	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000969	0.00107	CcSEcCtD
Prilocaine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000964	0.00107	CcSEcCtD
Prilocaine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000963	0.00107	CcSEcCtD
Prilocaine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000961	0.00106	CcSEcCtD
Prilocaine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000957	0.00106	CcSEcCtD
Prilocaine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000955	0.00106	CcSEcCtD
Prilocaine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000955	0.00106	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000952	0.0187	CbGpPWpGaD
Prilocaine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000951	0.00105	CcSEcCtD
Prilocaine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000943	0.00104	CcSEcCtD
Prilocaine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00094	0.00104	CcSEcCtD
Prilocaine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000938	0.00104	CcSEcCtD
Prilocaine—Pain—Vincristine—peripheral nervous system neoplasm	0.000938	0.00104	CcSEcCtD
Prilocaine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000938	0.00104	CcSEcCtD
Prilocaine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000938	0.00104	CcSEcCtD
Prilocaine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000938	0.00104	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000914	0.018	CbGpPWpGaD
Prilocaine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000906	0.001	CcSEcCtD
Prilocaine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000904	0.001	CcSEcCtD
Prilocaine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000904	0.001	CcSEcCtD
Prilocaine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000899	0.000995	CcSEcCtD
Prilocaine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000896	0.000992	CcSEcCtD
Prilocaine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000892	0.000988	CcSEcCtD
Prilocaine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000892	0.000988	CcSEcCtD
Prilocaine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000892	0.000987	CcSEcCtD
Prilocaine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000888	0.000984	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000882	0.0174	CbGpPWpGaD
Prilocaine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000881	0.000975	CcSEcCtD
Prilocaine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000881	0.000975	CcSEcCtD
Prilocaine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000871	0.000964	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000869	0.0171	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000859	0.000951	CcSEcCtD
Prilocaine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000839	0.000928	CcSEcCtD
Prilocaine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00083	0.000919	CcSEcCtD
Prilocaine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000829	0.000918	CcSEcCtD
Prilocaine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000817	0.000904	CcSEcCtD
Prilocaine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000808	0.000895	CcSEcCtD
Prilocaine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000799	0.000885	CcSEcCtD
Prilocaine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000798	0.000883	CcSEcCtD
Prilocaine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00079	0.000874	CcSEcCtD
Prilocaine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000787	0.000871	CcSEcCtD
Prilocaine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000781	0.000864	CcSEcCtD
Prilocaine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000781	0.000864	CcSEcCtD
Prilocaine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000765	0.000847	CcSEcCtD
Prilocaine—Pain—Etoposide—peripheral nervous system neoplasm	0.00076	0.000841	CcSEcCtD
Prilocaine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000753	0.000833	CcSEcCtD
Prilocaine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000749	0.000829	CcSEcCtD
Prilocaine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000732	0.00081	CcSEcCtD
Prilocaine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000729	0.000807	CcSEcCtD
Prilocaine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000725	0.000803	CcSEcCtD
Prilocaine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000724	0.000801	CcSEcCtD
Prilocaine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000723	0.0008	CcSEcCtD
Prilocaine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000715	0.000791	CcSEcCtD
Prilocaine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000714	0.00079	CcSEcCtD
Prilocaine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000784	CcSEcCtD
Prilocaine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000706	0.000781	CcSEcCtD
Prilocaine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000698	0.000772	CcSEcCtD
Prilocaine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000697	0.000772	CcSEcCtD
Prilocaine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000696	0.00077	CcSEcCtD
Prilocaine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000693	0.000767	CcSEcCtD
Prilocaine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.000748	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.000731	CcSEcCtD
Prilocaine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000655	0.000725	CcSEcCtD
Prilocaine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000654	0.000724	CcSEcCtD
Prilocaine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000651	0.000721	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000651	0.0128	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000647	0.0127	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.000714	CcSEcCtD
Prilocaine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000637	0.000706	CcSEcCtD
Prilocaine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000626	0.000693	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000626	0.0123	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00062	0.0122	CbGpPWpGaD
Prilocaine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000617	0.000683	CcSEcCtD
Prilocaine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000605	0.000669	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000603	0.0119	CbGpPWpGaD
Prilocaine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000599	0.000663	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000593	0.0117	CbGpPWpGaD
Prilocaine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000656	CcSEcCtD
Prilocaine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000588	0.00065	CcSEcCtD
Prilocaine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.000641	CcSEcCtD
Prilocaine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000576	0.000638	CcSEcCtD
Prilocaine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000637	CcSEcCtD
Prilocaine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000565	0.000625	CcSEcCtD
Prilocaine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000564	0.000624	CcSEcCtD
Prilocaine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.000613	CcSEcCtD
Prilocaine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.000607	CcSEcCtD
Prilocaine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000606	CcSEcCtD
Prilocaine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000594	CcSEcCtD
Prilocaine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000589	CcSEcCtD
Prilocaine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000528	0.000584	CcSEcCtD
Prilocaine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000527	0.000583	CcSEcCtD
Prilocaine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000578	CcSEcCtD
Prilocaine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000573	CcSEcCtD
Prilocaine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000561	CcSEcCtD
Prilocaine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000556	CcSEcCtD
Prilocaine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000551	CcSEcCtD
Prilocaine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000551	CcSEcCtD
Prilocaine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000549	CcSEcCtD
Prilocaine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00049	0.000542	CcSEcCtD
Prilocaine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000541	CcSEcCtD
Prilocaine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000487	0.00054	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000483	0.00951	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000533	CcSEcCtD
Prilocaine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.00053	CcSEcCtD
Prilocaine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000515	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000465	0.00915	CbGpPWpGaD
Prilocaine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000514	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.00051	CcSEcCtD
Prilocaine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.00051	CcSEcCtD
Prilocaine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000502	CcSEcCtD
Prilocaine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.0005	CcSEcCtD
Prilocaine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000495	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000447	0.00879	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000493	CcSEcCtD
Prilocaine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000443	0.00049	CcSEcCtD
Prilocaine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000477	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000431	0.00848	CbGpPWpGaD
Prilocaine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000471	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000424	0.00835	CbGpPWpGaD
Prilocaine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000458	CcSEcCtD
Prilocaine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00041	0.000454	CcSEcCtD
Prilocaine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000453	CcSEcCtD
Prilocaine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000438	CcSEcCtD
Prilocaine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000436	CcSEcCtD
Prilocaine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.00042	CcSEcCtD
Prilocaine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000406	CcSEcCtD
Prilocaine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000405	CcSEcCtD
Prilocaine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000396	CcSEcCtD
Prilocaine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000376	CcSEcCtD
Prilocaine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000366	CcSEcCtD
Prilocaine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000365	CcSEcCtD
Prilocaine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000351	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	0.000311	0.00613	CbGpPWpGaD
Prilocaine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000337	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000303	0.00596	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.000299	0.00589	CbGpPWpGaD
Prilocaine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000327	CcSEcCtD
Prilocaine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000324	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000288	0.00568	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000288	0.00567	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000277	0.00545	CbGpPWpGaD
Prilocaine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000303	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000267	0.00525	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000241	0.00475	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000228	0.00448	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000222	0.00437	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000219	0.0043	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000213	0.0042	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000211	0.00415	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000206	0.00405	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000205	0.00404	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000203	0.00399	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000197	0.00389	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00019	0.00375	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000187	0.00369	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000173	0.00341	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000166	0.00327	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000162	0.0032	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00016	0.00316	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000156	0.00307	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00015	0.00296	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000148	0.00292	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000145	0.00285	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000134	0.00263	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000127	0.00249	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000124	0.00243	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000122	0.0024	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000119	0.00234	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000117	0.00231	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000114	0.00225	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000113	0.00222	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000106	0.00208	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.04e-05	0.00178	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.68e-05	0.00171	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.37e-05	0.00165	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	8.25e-05	0.00162	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.04e-05	0.00158	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.98e-05	0.00157	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.67e-05	0.00151	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.39e-05	0.00146	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.89e-05	0.00116	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.2e-05	0.00102	CbGpPWpGaD
